About Natto Pharma
Natto Pharma is a company based in Oslo (Norway) founded in 2004 was acquired by Lesaffre in February 2021. Natto Pharma has completed 1 acquisition, including Kaydence Pharma. Natto Pharma operates in a competitive market with competitors including Kappa Bioscience, Deccan Healthcare, Kingdomway, AudiaCare and Pura Vida Health, among others.
- Headquarter Oslo, Norway
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$19.07 M (USD)-16as on Dec 31, 2022
-
Net Profit
$16.16 M (USD)507as on Dec 31, 2022
-
EBITDA
$17.37 M (USD)664as on Dec 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Lesaffre
(Feb 24, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Natto Pharma
Unlock access to complete
Funding Insights of Natto Pharma
Detailed funding history for Natto Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Natto Pharma
Natto Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lesaffre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of yeast and its related products
|
Locked | Locked | Locked |
Investor details for Natto Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Natto Pharma
Natto Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kaydence Pharma.
Investment portfolio details for Natto Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Fill and finish services are provided for biopharma products.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Natto Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Natto Pharma
Detailed financials for Natto Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Natto Pharma Comparisons
Peer comparison for Natto Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Natto Pharma
Natto Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kappa Bioscience, Deccan Healthcare, Kingdomway, AudiaCare and Pura Vida Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of nutraceutical and vitamin ingredients
|
|
| Locked | Locked | Locked |
Dietary supplements and vitamins are provided for healthy lifestyles.
|
|
| Locked | Locked | Locked |
Nutraceutical ingredients including DHA and ARA are manufactured by Kingdomway.
|
|
| Locked | Locked | Locked |
Vitamins, proteins, and organic products are manufactured by AudiaCare.
|
|
| Locked | Locked | Locked |
Non-profit organization promoting digital art, cultural events, and technology innovation.
|
Detailed competitors of Natto Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Natto Pharma
Complete news archive for Natto Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natto Pharma
Natto Pharma was founded in 2004.
Natto Pharma is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Annual revenue of Natto Pharma is $19.07M as on Dec 31, 2022.
Natto Pharma was founded in 2004 in Oslo, Norway, within the nutraceutical sector. Clinically validated and patented vitamin K2 products are produced and distributed under the MK-7 brand, available in pure and crystal forms. Operations focus on supplying these ingredients to other firms, including Sifar Pharma, Ven Pharma, and Agil Pharma. Certifications held include cGMP, ISO, GRAS, Non-GMO, Halal, and Kosher standards.
Natto Pharma's top competitors include Kingdomway, Deccan Healthcare and Kappa Bioscience.
Natto Pharma has made 1 acquisition, including Kaydence Pharma.
Natto Pharma has 1 investor. Key investors include Lesaffre.